Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT).
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT).
复制标题
接受自体造血干细胞移植 (aHSCT) 的原发性系统性淀粉样变性 (AL 淀粉样变性) 患者的治疗相关死亡率得到改善。
DOI:
--
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Efebera,YvonneA
中科院分区:
文献类型:
--
作者:
Pandit,Akshata;Wei,Lai;Bustamante,Luis;Elder,Patrick;Falk,WilliamBS;Sell,Megan;Rosko,Ashley;Benson,DonM;Devine,StevenM;Hofmeister,CraigC;Efebera,YvonneA